BioVie Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-50.26	-26.08	-183.85	-33.78	-2.49	-2.43	-1.33	-0.43	-0.23	-0.32
Depreciation & Amortization	0.23	0.23	0.23	0.23	0.23	0.23	0.23	0.05	0	0
Share-Based Compensation	6.38	6.19	3.02	0.02	0.06	0.24	0.09	0.01	0	0
Other Operating Activities	3.4	0.67	116.55	14.79	-0.35	1.32	0.39	0.22	0.17	0.15
Operating Cash Flow	-40.25	-18.99	-10.45	-1.63	-2.5	-0.62	-0.62	-0.15	-0.07	-0.17
Acquisitions	0	0	0	0	0	0	0	0.01	0	0
Change in Investments	-14.3	0	0	0	0	0	0	0	0	0
Investing Cash Flow	-14.3	0	0	0	0	0	0	0.01	0	0
Share Issuance / Repurchase	55.37	18.51	16.31	0	0	0.45	0.48	-0	0	0
Debt Issued / Paid	0	14.61	-1.39	1.33	-0.24	-0.04	0.03	0	0	0
Other Financing Activities	-	-	-	-	3.04	0.25	-	-	-	-
Financing Cash Flow	55.37	33.12	14.93	1.33	2.8	0.66	0.5	-0	0	0
Net Cash Flow	0.82	14.13	4.47	-0.3	0.29	0.04	-0.12	-0.14	-0.07	-0.17
Free Cash Flow	-40.25	-18.99	-10.45	-1.63	-2.5	-0.62	-0.62	-0.15	-0.07	-0.17
Free Cash Flow Per Share	-1.24	-0.77	-0.84	-0.33	-0.98	-0.81	-0.87	-0.22	-0.09	-0.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).